$700 Million is the total value of ARCH Venture Management, LLC's 8 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KRTX | KARUNA THERAPEUTICS, INC. | $369,323,000 | -3.2% | 2,912,872 | 0.0% | 52.78% | +30.7% | |
EQRX, INC. | $150,065,000 | -39.4% | 36,335,375 | 0.0% | 21.44% | -18.2% | ||
ERASCA, INC. | $95,078,000 | -44.8% | 11,055,554 | 0.0% | 13.59% | -25.4% | ||
VERV | VERVE THERAPEUTICS, INC. | $57,251,000 | -38.1% | 2,508,809 | 0.0% | 8.18% | -16.4% | |
OMIC | SINGULAR GENOMICS SYSTEMS, INC. | $23,971,000 | -45.4% | 3,798,926 | 0.0% | 3.43% | -26.3% | |
RUBY | RUBIUS THERAPEUTICS, INC. | $1,928,000 | -43.1% | 349,908 | 0.0% | 0.28% | -22.9% | |
MTCR | New | METACRINE, INC. | $1,793,000 | – | 2,940,503 | +100.0% | 0.26% | – |
ZY | ZYMERGEN INC. | $345,000 | -56.7% | 119,205 | 0.0% | 0.05% | -41.7% | |
PULM | Exit | PULMATRIX, INC. | $0 | – | -43,639 | -100.0% | -0.00% | – |
NTRA | Exit | NATERA, INC. | $0 | – | -32,098 | -100.0% | -0.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-05-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
EQRX, INC. | 8 | Q3 2023 | 52.4% |
ERASCA, INC. | 8 | Q3 2023 | 18.8% |
VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
CHIASMA INC | 8 | Q3 2020 | 25.7% |
SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-05-27 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.